Efficacy and safety of a novel, nebulized glycopyrrolate for the treatment of COPD: effect of baseline disease severity and age; pooled analysis of GOLDEN 3 and GOLDEN 4

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, December 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 27,892 followers.

RT @ChronicRights: Efficacy and safety of a novel, nebulized glycopyrrolate for the treat | #COPD - Dove Medical Press - https://t.co/kVPns…

RT @ChronicRights: Efficacy and safety of a novel, nebulized glycopyrrolate for the treat | #COPD - Dove Medical Press - https://t.co/kVPns…

RT @ChronicRights: Efficacy and safety of a novel, nebulized glycopyrrolate for the treat | #COPD - Dove Medical Press - https://t.co/kVPns…

RT @ChronicRights: Efficacy and safety of a novel, nebulized glycopyrrolate for the treat | #COPD - Dove Medical Press - https://t.co/kVPns…

Efficacy and safety of a novel, nebulized glycopyrrolate for the treat | #COPD - Dove Medical Press - https://t.co/kVPnsjpJSf